• Most Recent
• Highest Rated
• Hot Comments

Florida BioTechnology News

• BIO 2012 World Congress Plenary program

  • Fostering a Biobased Economy • A Global Vision for Biomass Utilization: How Biotech Can Get Us There • The Future of Biocatalysis in Global Manufacturing • Promoting Biotech Innovation • Financing Innovation in the Industrial Biotech Space: Creative Models and Future Trends • What’s Driving Demand for Biotech Products?: A Customer’s Perspective Featured plenary speakers [...]
  Share  |  Rate

• Roskamp drug in Phase III trial

  More than 500 Alzheimer’s patients in nine European countries will participate in a phase III trial designed to study the effectiveness of Nilvadipine, an Alzheimer’s disease drug developed at the Roskamp Institute in Sarasota, Florida.

  “We believe that Nilvadipine blocks the production of amyloid proteins linked to Alzheimer’s disease,” said Roskamp [...]

  Share  |  Rate

• UF tests gene therapy for epilepsy to prevent seizures

  Sparking production of a hormone in the brain that people with epilepsy often lack could prevent debilitating seizures, University of Florida researchers have discovered.

  The researchers used gene therapy in rats to stimulate production of somatostatin, a seizure-stopping chemical that naturally occurs in the brain. The study was published in the February [...]

  Share  |  Rate

• Antibiotics get reinforcements in fight against superbugs

  A compound that makes existing antibiotics 16 times more effective against recently discovered antibiotic-resistant “superbugs.” has been developed at North Carolina State University.

  These so-called superbugs are actually bacterial strains that produce an enzyme known as New Delhi metallo-β-lactamase (NDM-1). Bacteria that produce this enzyme are practically impervious to antibiotics because NDM-1renders [...]

  Share  |  Rate

• A frozen budget for the NIH will flat line medical breakthroughs

  “The president’s recommendation for NIH fails to capitalize on the power of this funding to drive new businesses, new jobs and new treatments,” said Research!America Chair, former Congressman John Edward Porter. “We simply cannot freeze investments in biomedical research. The consequences would be disastrous as global competition intensifies.”

  According to recent [...]

  Share  |  Rate